Story perspectives

Breakthrough Tools for Early Detection of Fatty Liver Disease

3/19/2026

Summary

Story summary

Researchers from Fudan University identify ultrasound-derived fat fraction (UDFF) as a promising noninvasive diagnostic tool.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the renamed fatty liver disease and a global issue linked to obesity and diabetes.
A University of Connecticut (UConn) team developed a therapy targeting long noncoding RNA HNF4A-AS1 to reverse liver damage.
New drug developments are underway.
Early detection and intervention are crucial for MASLD.

1 of 1

Story summary

Researchers from Fudan University identify ultrasound-derived fat fraction (UDFF) as a promising noninvasive diagnostic tool.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the renamed fatty liver disease and a global issue linked to obesity and diabetes.
A University of Connecticut (UConn) team developed a therapy targeting long noncoding RNA HNF4A-AS1 to reverse liver damage.
New drug developments are underway.
Early detection and intervention are crucial for MASLD.